Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Title
Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF OPHTHALMOLOGY
Volume 145, Issue 2, Pages 239-248.e5
Publisher
Elsevier BV
Online
2008-01-28
DOI
10.1016/j.ajo.2007.10.004

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation